山东医学高等专科学校学报
山東醫學高等專科學校學報
산동의학고등전과학교학보
JOURNAL OF SHANDONG MEDICAL COLLEGE
2014年
3期
165-168
,共4页
脑梗死%血栓前状态%奥扎格雷钠%低分子肝素钙
腦梗死%血栓前狀態%奧扎格雷鈉%低分子肝素鈣
뇌경사%혈전전상태%오찰격뢰납%저분자간소개
Cerebral infarction%Prethrombotic state%Ozagrel Sodium%Low Molecular Weight Heparin Caleium
目的:观察奥扎格雷钠联合低分子肝素钙对急性脑梗死患者血栓前状态的影响及临床疗效。方法急性脑梗死患者126例,随机分为A、B、C三组各42例,A组给予奥扎格雷钠及低分子肝素钙治疗,B组给予奥扎格雷钠,C组给予低分子肝素钙。治疗前后对3组患者进行临床神经功能缺损程度评分及检测血栓前状态指标v W F、G M P140的变化,同时监测药物不良反应。结果治疗后,A组神经功能损伤评分显著低于B组和C组( P <0.05),三组血栓前状态标志物血清vWF、GMP140水平较治疗前显著下降,且A组患者显著低于B、C两组( P <0.05),三组患者均无明显不良反应。结论急性脑梗死患者奥扎格雷钠联合低分子肝素钙治疗能有效抑制血小板活化,改善血栓前状态,对改善长期临床预后有一定影响。
目的:觀察奧扎格雷鈉聯閤低分子肝素鈣對急性腦梗死患者血栓前狀態的影響及臨床療效。方法急性腦梗死患者126例,隨機分為A、B、C三組各42例,A組給予奧扎格雷鈉及低分子肝素鈣治療,B組給予奧扎格雷鈉,C組給予低分子肝素鈣。治療前後對3組患者進行臨床神經功能缺損程度評分及檢測血栓前狀態指標v W F、G M P140的變化,同時鑑測藥物不良反應。結果治療後,A組神經功能損傷評分顯著低于B組和C組( P <0.05),三組血栓前狀態標誌物血清vWF、GMP140水平較治療前顯著下降,且A組患者顯著低于B、C兩組( P <0.05),三組患者均無明顯不良反應。結論急性腦梗死患者奧扎格雷鈉聯閤低分子肝素鈣治療能有效抑製血小闆活化,改善血栓前狀態,對改善長期臨床預後有一定影響。
목적:관찰오찰격뢰납연합저분자간소개대급성뇌경사환자혈전전상태적영향급림상료효。방법급성뇌경사환자126례,수궤분위A、B、C삼조각42례,A조급여오찰격뢰납급저분자간소개치료,B조급여오찰격뢰납,C조급여저분자간소개。치료전후대3조환자진행림상신경공능결손정도평분급검측혈전전상태지표v W F、G M P140적변화,동시감측약물불량반응。결과치료후,A조신경공능손상평분현저저우B조화C조( P <0.05),삼조혈전전상태표지물혈청vWF、GMP140수평교치료전현저하강,차A조환자현저저우B、C량조( P <0.05),삼조환자균무명현불량반응。결론급성뇌경사환자오찰격뢰납연합저분자간소개치료능유효억제혈소판활화,개선혈전전상태,대개선장기림상예후유일정영향。
Objective To observe the curative effect of ozagrel sodium combined with low molecular weight hepa-rin calcium(LMWHC) on the prethrombotic state of patients with acute cerebral infarction .Methods 126 patients were randomly divided into 3 groups .Group A was treated with ozagrel sodium combined with LMWHC (n=42) , Group B with ozagrel Sodium (n=42) and Group C with LMWHC (n=42) .Before and after the treatments ,the nervous function damage degree (NDS) of the 3 groups was scored and the prethrombotic state markers (vWF and GMP140) were checked ,and the side effects were recorded at the same time .Results After treatment ,NDS in Group A were much lower than those in Group B and Group C .The markers of Serum levels of vWF and GMP-140 were all reduced in three groups after treatment ,which were much lower in Group A than those in Group B and Group C ( P<0 .05) .No serious side effects happened .Conclusion LMWHC in combination with Ozagrel So-dium can suppress the progress of platelet activation ,ameliorate the prethrombotic state and have a certain effect on the long-term prognosis of patients with acute cerebral infarction .